1020 Wellness

1020 Wellness operates in Birmingham, Alabama, under the clinical direction of John M. Morgan, MD, a Certified BioTE Provider who integrates peptide therapy with hormone optimization and medical aesthetics. The clinic addresses metabolic dysfunction, hormonal imbalances, and age-related aesthetic concerns through evidence-based protocols that combine pharmaceutical-grade peptides with bioidentical hormone replacement. Dr. Morgan's BioTE certification reflects specialized training in pellet-based hormone delivery systems, which the clinic pairs with complementary peptide interventions to support weight management, body composition changes, and skin rejuvenation in Birmingham-area patients seeking alternatives to conventional endocrinology or cosmetic dermatology.

Semaglutide represents the clinic's primary peptide offering for weight loss, administered through subcutaneous injection protocols that mimic incretin hormones to regulate appetite and glucose metabolism. Patients typically receive weekly injections with dosing titrated based on individual tolerance and weight loss velocity, often combined with nutritional counseling and body composition monitoring. The clinic structures semaglutide programs to address obesity, prediabetes, and metabolic syndrome, with treatment plans extending from three to twelve months depending on weight loss goals. Beyond semaglutide, 1020 Wellness incorporates hormone replacement therapy using BioTE pellet implants—rice-sized bioidentical hormone pellets inserted subcutaneously that release consistent testosterone or estradiol levels over three to five months—addressing symptoms of andropause, menopause, and age-related hormone decline that often complicate weight management efforts.

Dr. Morgan evaluates patients through comprehensive metabolic panels, hormone assays including total and free testosterone, estradiol, thyroid function tests, and hemoglobin A1c to establish baseline endocrine status before initiating peptide or hormone therapy. His approach emphasizes identifying root causes of weight gain—insulin resistance, thyroid dysfunction, sex hormone imbalances—rather than treating obesity as an isolated condition. Patients undergo initial consultations that include medical history review, physical examination, and discussion of realistic outcomes based on individual metabolic profiles. The clinic's aesthetic services, including injectable treatments for facial volume restoration and skin texture improvement, complement peptide and hormone therapies by addressing visible aging signs that patients often seek to improve alongside metabolic health optimization.

The patient experience at 1020 Wellness in Birmingham centers on in-person consultations and ongoing monitoring, with follow-up visits scheduled at four to six week intervals during active treatment phases. Semaglutide patients receive injection training during their first visit, with options for self-administration at home or in-office injections based on comfort level and preference. The clinic provides detailed protocols for managing common side effects—nausea, constipation, injection site reactions—and adjusts dosing schedules when gastrointestinal symptoms limit treatment adherence. Hormone pellet patients return for pellet insertion procedures performed in-office under local anesthesia, with follow-up hormone level testing at six to eight weeks post-insertion to confirm therapeutic ranges. This hands-on model allows Dr. Morgan to track treatment response through objective measures: weight trends, body composition changes via bioimpedance analysis, symptom resolution scores, and repeat laboratory values.

1020 Wellness differentiates itself in the Birmingham medical wellness market through its integration of three distinct but complementary service lines—peptide-based weight loss, bioidentical hormone replacement, and aesthetic medicine—under one clinical roof with a board-certified physician. The clinic's BioTE certification provides access to proprietary hormone pellet formulations and dosing algorithms not available through standard compounding pharmacies, while the focus on semaglutide positions the practice at the intersection of endocrinology and obesity medicine. With a 4.8-star rating across 26 Google reviews, the clinic has established a reputation for accessible peptide therapy in Alabama, where patients previously required referrals to academic medical centers or out-of-state telemedicine providers for GLP-1 agonist weight loss programs. The in-person consultation model ensures Alabama residents receive face-to-face evaluation, hands-on injection training, and local follow-up care without the limitations of telehealth-only peptide services.